Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • About HHS
  • Programs & Services
  • Grants & Contracts
  • Laws & Regulations
  • Radical Transparency
  • Big Wins
  • About OHRP
  • Regulations, Policy & Guidance
  • Education & Outreach
  • Compliance & Reporting
  • News & Events
  • Register IRBs & Obtain FWAs
  • SACHRP Committee
  • International
Breadcrumb
  1. HHS
  2. OHRP
  3. News
  4. Announcements & News Releases
  5. 2025 Announcements & News Releases
  6. Draft Guidance on Conditions for Including Tissue Biopsies in Clinical Trials
  • Announcements & News Releases
  • OHRP Newsletters
    • 2025 Newsletters
    • 2024 Newsletters
    • 2023 Newsletters
    • 2022 Newsletters
  • Sign up for Announcements
  • Events
  • Past Events
  • Federal Register Notices

Draft Guidance on Conditions for Including Tissue Biopsies in Clinical Trials

January 7, 2025

On January 7, 2025, the Office for Human Research Protections (OHRP) and the U.S. Food and Drug Administration issued a draft guidance with that, when finalized, will provide recommendations about including tissue biopsies as part of clinical trials, and provide considerations for determining if a tissue biopsy should be required or optional.  The draft guidance is intended, when finalized, to assist industry, clinical investigators, institutions, and institutional review boards in understanding considerations for tissue biopsies in adults and children as part of clinical trials that evaluate investigational medical products and/or that are conducted or supported by the U.S. Department of Health and Human Services (HHS).

Comments about the draft guidance, “Considerations for Including Tissue Biopsies in Clinical Trials: Guidance for Industry, Investigators, Institutions, and IRBs,” can be submitted through March 10, 2025, by following instructions in the Federal Register (90 FR 1173), which can be accessed here: https://www.federalregister.gov/documents/2025/01/07/2024-31536/considerations-for-including-tissue-biopsies-in-clinical-trials-draft-guidance-for-industry

The text of the draft guidance document appears on OHRP’s website (https://www.hhs.gov/ohrp/regulations-and-policy/requests-for-comments/draft-guidance-considerations-including-tissue-biopsies-clinical-trials/index.html) and is also available on FDA’s website.

###
Like HHS on FacebookExit disclaimer icon, follow HHS on X @HHSgov Exit disclaimer icon, and sign up for HHS Email Updates Exit disclaimer icon.
Content created by Office for Human Research Protections (OHRP)
Content last reviewed January 7, 2025
Back to top

Subscribe to Email Updates

Receive the latest updates from the Secretary and Press Releases.

Subscribe
  • Contact HHS
  • Careers
  • HHS FAQs
  • Nondiscrimination Notice
  • Press Room
  • HHS Archive
  • Accessibility Statement
  • Privacy Policy
  • Budget/Performance
  • Inspector General
  • Web Site Disclaimers
  • EEO/No Fear Act
  • FOIA
  • The White House
  • USA.gov
  • Vulnerability Disclosure Policy
HHS Logo

HHS Headquarters

200 Independence Avenue, S.W.
Washington, D.C. 20201
Toll Free Call Center: 1-877-696-6775​

Follow HHS

Follow Secretary Kennedy